Sfoglia per AUTORE
RIGANTI C
Collezione AOU San Luigi di Orbassano

  

Items : 13

Ecteinascidin synthetic analogues: a new class of selective inhibitors of transcription, exerting immunogenic cell death in refractory malignant pleural mesothelioma. in Journal of experimental & clinical cancer research : CR / J Exp Clin Cancer Res. 2024 Dec 21;43(1):327. doi: 10.1186/s13046-024-03253-y.
2024
AOU San Luigi di Orbassano

Salaroglio IC; Aviles P; Kopecka J; Merlini A; Napoli F; Righi L; Novello S; Sullivan H; Cuevas C; Scagliotti GV; Riganti C;

Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2023 Feb 1;29(3):621-634. doi: 10.1158/1078-0432.CCR-22-0761.
2023
AOU San Luigi di Orbassano

Rotolo R; Leuci V; Donini C; Galvagno F; Massa A; De Santis MC; Peirone S; Medico G; Sanlorenzo M; Vujic I; Gammaitoni L; Basiricò M; Righi L; Riganti C; Salaroglio IC; Napoli F; Tabbò F; Mariniello A; Vigna E; Modica C; D'Ambrosio L; Grignani G; Taulli R; Hirsch E; Cereda M; Aglietta M; Scagliotti GV; Novello S; Bironzo P; et alii...

SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma. in Journal of experimental & clinical cancer research : CR / J Exp Clin Cancer Res. 2022 Feb 23;41(1):75. doi: 10.1186/s13046-022-02284-7.
2022
AOU San Luigi di Orbassano

Salaroglio IC; Belisario DC; Bironzo P; Ananthanarayanan P; Ricci L; Digiovanni S; Fontana S; Napoli F; Sandri A; Facolmatà C; Libener R; Comunanza V; Grosso F; Gazzano E; Leo F; Taulli R; Bussolino F; Righi L; Papotti MG; Novello S; Scagliotti GV; Riganti C; Kopecka J;

Correction to: Micro-RNA-215 and -375 regulate thymidylate synthase protein expression in pleural mesothelioma and mediate epithelial to mesenchymal transition. in Virchows Archiv : an international journal of pathology / Virchows Arch. 2022 Aug;481(2):331. doi: 10.1007/s00428-022-03355-y.
2022
AOU San Luigi di Orbassano

Napoli F; Rapa I; Izzo S; Rigutto A; Libener R; Riganti C; Bironzo P; Taulli R; Papotti M; Volante M; Scagliotti G; Righi L;

Micro-RNA-215 and -375 regulate thymidylate synthase protein expression in pleural mesothelioma and mediate epithelial to mesenchymal transition. in Virchows Archiv : an international journal of pathology / Virchows Arch. 2022 Aug;481(2):233-244. doi: 10.1007/s00428-022-03321-8. Epub 2022 Apr 24.
2022
AOU San Luigi di Orbassano

Napoli F; Rapa I; Izzo S; Rigutto A; Libener R; Riganti C; Bironzo P; Taulli R; Papotti M; Volante M; Scagliotti G; Righi L;

Evaluation of the Preclinical Efficacy of Lurbinectedin in Malignant Pleural Mesothelioma. in Cancers / Cancers (Basel). 2021 May 12;13(10):2332. doi: 10.3390/cancers13102332.
2021
AOU Alessandria
AOU San Luigi di Orbassano

Aviles P; Libener R; Leo F; Guerrera F; Sandri A; Comunanza V; Gigliotti C; Bussolino F; Di Nicolantonio F; Pittaro A; Papotti MG; Napoli F; Righi L; Morena D; Lingua MF; Picca F; Bironzo P; Anobile DP; Novello S; Taulli R; Scagliotti GV; Riganti C;

Wnt/IL-1?/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5. in International journal of cancer / Int J Cancer. 2020 Jan 1;146(1):192-207. doi: 10.1002/ijc.32419. Epub 2019 Jun 4.
2020
AOU San Luigi di Orbassano

Milosevic V; Kopecka J; Salaroglio IC; Libener R; Napoli F; Izzo S; Orecchia S; Ananthanarayanan P; Bironzo P; Grosso F; Tabbò F; Comunanza V; Alexa-Stratulat T; Bussolino F; Righi L; Novello S; Scagliotti GV; Riganti C; Milosevic V; Kopecka J; Salaroglio IC; Libener R; Napoli F; Izzo S; Orecchia S; Ananthanarayanan P; Bironzo P; Grosso F; Tabbò F; et alii...

Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma. in Proceedings of the National Academy of Sciences of the United States of America / Proc Natl Acad Sci U S A. 2019 Feb 5;116(6):2226-2231. doi: 10.1073/pnas.1818865116. Epub 2019 Jan 1
2019
AOU San Luigi di Orbassano

Villanova T; Gesmundo I; Audrito V; Vitale N; Silvagno F; Musuraca C; Righi L; Libener R; Riganti C; Bironzo P; Deaglio S; Papotti M; Cai R; Sha W; Ghigo E; Schally AV; Granata R;

Potential Diagnostic and Prognostic Role of Microenvironment in Malignant Pleural Mesothelioma. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2019 Aug;14(8):1458-1471. doi: 10.1016/j.jtho.2019.03.029. Epub 2019 May 9.
2019
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Riganti C; Scagliotti GV; Papotti M; Di Maio M; Novello S; Righi L; Ruffini E; Bussolino F; Ardissone F; Comunanza V; Passone E; Cartia CF; Tabbò F; Ananthanarayanan P; Bironzo P; Gagliasso M; Milosevic V; Costardi L; Maletta F; Salaroglio IC; Kopecka J; Napoli F; Pradotto M;

Loss of C/EBP-? LIP drives cisplatin resistance in malignant pleural mesothelioma. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2018 Jun;120:34-45. doi: 10.1016/j.lungcan.2018.03.022. Epub 2018 Mar 26.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Rubinstein M; Novello S; Di Maio M; Napoli F; Pradotto M; Capelletto E; Ricci L; Ananthanarayanan P; Milosevic V; Grosso F; Libener R; Orecchia S; Salaroglio IC; Righi L; Kopecka J; Scagliotti GV; Riganti C;

Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment. in Oncoimmunology / Oncoimmunology. 2017 Nov 27;7(3):e1398874. doi: 10.1080/2162402X.2017.1398874. eCollection 2018.
2018
AOU San Luigi di Orbassano

Riganti C; Lingua MF; Salaroglio IC; Falcomatà C; Righi L; Morena D; Picca F; Oddo D; Kopecka J; Pradotto M; Libener R; Orecchia S; Bironzo P; Comunanza V; Bussolino F; Novello S; Scagliotti GV; Di Nicolantonio F; Taulli R; Riganti C; Lingua MF; Salaroglio IC; Falcomatà C; Righi L; Morena D; Picca F; Oddo D; Kopecka J; Pradotto M; et alii...

Two repeated low doses of doxorubicin are more effective than a single high dose against tumors overexpressing P-glycoprotein. in Cancer letters / Cancer Lett. 2015 May 1;360(2):219-26. doi: 10.1016/j.canlet.2015.02.008. Epub 2015 Feb 11.
2015
AOU San Luigi di Orbassano

Riganti C; Gazzano E; Gulino GR; Volante M; Ghigo D; Kopecka J;

2006
AOU San Luigi di Orbassano

Doronzo G; Russo I; Mattiello L; Riganti C; Anfossi G; Trovati M;

©2024 Tutti i diritti riservati. Biblioteca Virtuale per la Salute - Piemonte